Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-16

FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' supplemental application for metoprolol succinate ER tablets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL SUCCINATE ER TABLETS (Metoprolol succinate ER tablets)

Snippet

SUPPL AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE ER TABLETS)